X-108686060-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PP2PP3_ModerateBS2_Supporting

The NM_033380.3(COL4A5):​c.4246C>T​(p.Arg1416Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000513 in 1,208,887 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1416H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000081 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000048 ( 0 hom. 22 hem. )

Consequence

COL4A5
NM_033380.3 missense

Scores

8
3
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:8B:1

Conservation

PhyloP100: 0.472
Variant links:
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 538 curated pathogenic missense variants (we use a threshold of 10). The gene has 138 curated benign missense variants. Gene score misZ: 2.4995 (below the threshold of 3.09). GenCC associations: The gene is linked to X-linked Alport syndrome, Alport syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.851
BS2
High Hemizygotes in GnomAd4 at 2 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A5NM_033380.3 linkc.4246C>T p.Arg1416Cys missense_variant Exon 48 of 53 ENST00000328300.11 NP_203699.1 P29400-2Q49AM6A7MBN3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A5ENST00000328300.11 linkc.4246C>T p.Arg1416Cys missense_variant Exon 48 of 53 1 NM_033380.3 ENSP00000331902.7 P29400-2

Frequencies

GnomAD3 genomes
AF:
0.0000807
AC:
9
AN:
111494
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000653
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000951
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000942
Gnomad OTH
AF:
0.000671
GnomAD2 exomes
AF:
0.0000383
AC:
7
AN:
182632
AF XY:
0.0000744
show subpopulations
Gnomad AFR exome
AF:
0.0000762
Gnomad AMR exome
AF:
0.0000731
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000491
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000483
AC:
53
AN:
1097339
Hom.:
0
Cov.:
30
AF XY:
0.0000606
AC XY:
22
AN XY:
362783
show subpopulations
Gnomad4 AFR exome
AF:
0.000114
AC:
3
AN:
26379
Gnomad4 AMR exome
AF:
0.0000569
AC:
2
AN:
35168
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
19374
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
30176
Gnomad4 SAS exome
AF:
0.0000185
AC:
1
AN:
54077
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
40493
Gnomad4 NFE exome
AF:
0.0000547
AC:
46
AN:
841545
Gnomad4 Remaining exome
AF:
0.0000217
AC:
1
AN:
46056
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000807
AC:
9
AN:
111548
Hom.:
0
Cov.:
23
AF XY:
0.0000593
AC XY:
2
AN XY:
33744
show subpopulations
Gnomad4 AFR
AF:
0.0000652
AC:
0.0000651551
AN:
0.0000651551
Gnomad4 AMR
AF:
0.0000950
AC:
0.0000950119
AN:
0.0000950119
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.0000942
AC:
0.000094185
AN:
0.000094185
Gnomad4 OTH
AF:
0.000663
AC:
0.000662691
AN:
0.000662691
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000359
Hom.:
0
Bravo
AF:
0.0000567
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.0000824
AC:
10
EpiCase
AF:
0.000327
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:8Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

X-linked Alport syndrome Uncertain:4
Aug 17, 2021
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 28, 2021
MGZ Medical Genetics Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 10, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 28, 2017
Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Uncertain:2Benign:1
Feb 02, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Occurs in the triple helical domain at the X position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the X position is not a common mechanism of disease; This variant is associated with the following publications: (PMID: 8651296, 9452056) -

Sep 16, 2018
Gharavi Laboratory, Columbia University
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Oct 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:2
May 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: COL4A5 c.4228C>T (p.Arg1410Cys) results in a non-conservative amino acid change located in the triple-helical region of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.8e-05 in 182632 control chromosomes in the gnomAD database, including 5 hemizygotes, providing evidence supporting a benign role. c.4228C>T has been reported in the literature in at least one male individual and as a heterozygous genotype in one female individual affected with Alport Syndrome 1, X-Linked Recessive, and in both cases, the variant was reported to segregate with the disease phenotype, however no additional information (i.e. pedigrees, number and/or genotype of affected or unaffected family members) was provided. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 9452056, 35580552, 8651296). Seven submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as either VUS (n=6) or likely benign (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. -

May 04, 2022
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Pathogenic
0.33
D
BayesDel_noAF
Pathogenic
0.42
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.82
.;D
FATHMM_MKL
Benign
0.55
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Pathogenic
0.71
D
MetaRNN
Pathogenic
0.85
D;D
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Uncertain
2.6
.;M
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-2.8
D;D
REVEL
Pathogenic
0.65
Sift
Benign
0.11
T;D
Sift4G
Benign
0.067
T;D
Polyphen
1.0
.;D
Vest4
0.89
MVP
0.98
MPC
1.2
ClinPred
0.58
D
GERP RS
5.1
Varity_R
0.37
gMVP
0.47
Mutation Taster
=73/27
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104886270; hg19: chrX-107929290; COSMIC: COSV60377043; API